| First Author | Brocker CN | Year | 2018 |
| Journal | J Lipid Res | Volume | 59 |
| Issue | 11 | Pages | 2140-2152 |
| PubMed ID | 30158201 | Mgi Jnum | J:267215 |
| Mgi Id | MGI:6256618 | Doi | 10.1194/jlr.M088419 |
| Citation | Brocker CN, et al. (2018) Extrahepatic PPARalpha modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice. J Lipid Res 59(11):2140-2152 |
| abstractText | PPARalpha (PPARA), expressed in most oxidative tissues, is a major regulator of lipid homeostasis; hepatic PPARA plays a critical role during the adaptive fasting response by promoting FA oxidation (FAO). To clarify whether extrahepatic PPARA activity can protect against lipid overload when hepatic PPARA is impaired, lipid accumulation was compared in WT (Ppara (+/+)), total body Ppara-null (Ppara (-/-)), and hepatocyte-specific Ppara-null (Ppara (DeltaHep)) mice that were fasted for 24 h. Histologic staining indicated reduced lipid accumulation in Ppara (DeltaHep) versus Ppara (-/-) mice, and biochemical analyses revealed diminished medium- and long-chain FA accumulation in Ppara (DeltaHep) mouse livers. Hepatic PPARA target genes were suppressed in both mouse models. Serum FFAs increased in all genotypes after fasting but were highest in Ppara (-/-) mice. In Ppara (DeltaHep) mice, FAO genes were increased in brown adipose tissue, heart, and muscle, and total lipase activity was elevated in the muscle and heart, suggesting increased lipid utilization. Thus, extrahepatic PPARA activity reduces systemic lipid load when hepatic lipid metabolism is impaired by elevating FAO and lipase activity in other tissues and, as a result, protects against fasting-induced hepatosteatosis. This has important clinical implications in disease states with impaired hepatic PPARA function, such as nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. |
